Studies have shown that patients with type 2 diabetes mellitus, chronic kidney disease, acute kidney injury, Mycobacterium tuberculosis infection, and sepsis show increased resistin levels in plasma but also an increased occurrence of infections (68, 96, 112–114). This evidence concerns the gene RETN and type 2 diabetes mellitus.